トリグリセリド/HDL比と心筋損傷の潜在的関連性
Velia Cassano1, Graziella D'Arrigo2, Mercedes Gori3
1Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy.
Diabetes research and clinical practice
|August 30, 2025
まとめ
トリグリセリドと高密度の脂質タンパク質コレステロール (TG/HDL-C) の比率は,早期の心血管疾患リスクの単純なマーカーです. 患者のTG/HDL-C比の増加は,症状がない場合でも,サブクリニカル心筋機能不全を示す.
科学分野:
- 心臓病科
- メタボリックシンドローム
- バイオマーカー
背景:
- トリグリセリドと高密度脂質コレステロール (TG/HDL-C) の比率は,心血管疾患の予測因子として認識されています.
- サブクリニカルな心筋損傷は心血管リスクの初期指標です.
研究 の 目的:
- 心血管リスク因子としてTG/HDL-C比を評価する.
- TG/HDL-C比と亜臨床性心筋損傷の相関性を調査する.
主な方法:
- 545人の患者は口服によるグルコース耐性検査 (OGTT) を受けた.
- TG/ HDL-C比はトリグリセリドとHDLコレステロール濃度を用いて計算された.
- 患者はTG/ HDL- C値に基づいて四分位に分けられた.
主要な成果:
- グルコース代謝とインスリン感受性の漸進的な悪化は,TG/ HDL- C四分位数全体で観察されました.
- 静脈機能の測定値である左心室全長ストレンス (GLS) は四分位数全体で徐々に悪化した.
- TG/ HDL- C比の1単位増加は,病理的なGLSの確率の61%増加と関連していました.
結論:
- 高いTG/HDL-C比は,臨床症状とは関係なく,サブクリニック性心筋機能不全と関連しています.
- TG/HDL-C比は,早期の心血管リスクの特定に直接的で価値のあるマーカーとして機能します.
関連する概念動画
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Blood Studies for Cardiovascular System III: Serum Lipid Profile
291
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
291
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33


